Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 276 - 300 of 6046 in total
Sub Class ▲ LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Diacylglycerophosphoinositolglycans LMGP15010078
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:2(9Z,12Z)/18:0)
126457446 1186.662783 C57H103O23P
Diacylglycerophosphoinositolglycans LMGP15010079
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:2(9Z,12Z)/18:1(9Z))
126457447 1184.647133 C57H101O23P
Diacylglycerophosphoinositolglycans LMGP15010080
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:0/14:0)
126457448 1148.647133 C54H101O23P
Diacylglycerophosphoinositolglycans LMGP15010081
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:0/16:0)
126457449 1176.678433 C56H105O23P
Diacylglycerophosphoinositolglycans LMGP15010082
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:0/16:1(9Z))
126457450 1174.662783 C56H103O23P
Diacylglycerophosphoinositolglycans LMGP15010083
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:0/16:2(9Z,12Z))
126457451 1172.647133 C56H101O23P
Diacylglycerophosphoinositolglycans LMGP15010084
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:0/18:0)
126457452 1204.709733 C58H109O23P
Diacylglycerophosphoinositolglycans LMGP15010085
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:0/18:1(9Z))
126457453 1202.694083 C58H107O23P
Diacylglycerophosphoinositolglycans LMGP15010086
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:1(9Z)/14:0)
126457454 1146.631483 C54H99O23P
Diacylglycerophosphoinositolglycans LMGP15010087
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:1(9Z)/16:0)
126457455 1174.662783 C56H103O23P
Diacylglycerophosphoinositolglycans LMGP15010088
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:1(9Z)/16:1(9Z))
126457456 1172.647133 C56H101O23P
Diacylglycerophosphoinositolglycans LMGP15010089
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:1(9Z)/16:2(9Z,12Z))
126457457 1170.631483 C56H99O23P
Diacylglycerophosphoinositolglycans LMGP15010090
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:1(9Z)/18:0)
126457458 1202.694083 C58H107O23P
Diacylglycerophosphoinositolglycans LMGP15010091
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:1(9Z)/18:1(9Z))
126457459 1200.678433 C58H105O23P
Diacylglycerophosphoinositolglycans LMGP15010092
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:2(9Z,12Z)/14:0)
126457460 1144.615833 C54H97O23P
Diacylglycerophosphoinositolglycans LMGP15010093
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:2(9Z,12Z)/16:0)
126457461 1172.647133 C56H101O23P
Diacylglycerophosphoinositolglycans LMGP15010094
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:2(9Z,12Z)/16:1(9Z))
126457462 1170.631483 C56H99O23P
Diacylglycerophosphoinositolglycans LMGP15010095
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:2(9Z,12Z)/16:2(9Z,12Z))
126457463 1168.615833 C56H97O23P
Diacylglycerophosphoinositolglycans LMGP15010096
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:2(9Z,12Z)/18:0)
126457464 1200.678433 C58H105O23P
Diacylglycerophosphoinositolglycans LMGP15010097
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:2(9Z,12Z)/18:1(9Z))
126457465 1198.662783 C58H103O23P
Diacylglycerophosphoinositolglycans LMGP15010098
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(16:0/14:0)
126457466 1268.653008 C57H105O28P
Diacylglycerophosphoinositolglycans LMGP15010099
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(16:0/16:0)
126457467 1296.684308 C59H109O28P
Diacylglycerophosphoinositolglycans LMGP15010100
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(16:0/16:1(9Z))
126457468 1294.668658 C59H107O28P
Diacylglycerophosphoinositolglycans LMGP15010101
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(16:0/16:2(9Z,12Z))
126457469 1292.653008 C59H105O28P
Diacylglycerophosphoinositolglycans LMGP15010102
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(16:0/18:0)
126457470 1324.715608 C61H113O28P

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024